Tan et al. [31] demonstrated that among CHB patients who had age < 30 years and normal ALT levels, the prevalence of significant liver inflammation and fibrosis was 18.2% and 12.5% for HBeAg-positive patients, and 20.0% and 8.7% for HBeAg-negative patients, respectively. This evidence concerns the gene GPT and Hepatitis.